PMC:7127386 / 9927-10073 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"240","span":{"begin":97,"end":111},"obj":"Disease"}],"attributes":[{"id":"A240","pred":"tao:has_database_id","subj":"240","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"192564-14-0 N.D. \u003e100 N.D. N.D.\nDalbavancin hydrochloride antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 2"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T30","span":{"begin":97,"end":101},"obj":"Body_part"}],"attributes":[{"id":"A30","pred":"fma_id","subj":"T30","obj":"http://purl.org/sig/ont/fma/fma7163"}],"text":"192564-14-0 N.D. \u003e100 N.D. N.D.\nDalbavancin hydrochloride antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 2"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T6","span":{"begin":97,"end":101},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"}],"text":"192564-14-0 N.D. \u003e100 N.D. N.D.\nDalbavancin hydrochloride antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 2"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T63","span":{"begin":97,"end":111},"obj":"Disease"},{"id":"T64","span":{"begin":102,"end":111},"obj":"Disease"}],"attributes":[{"id":"A63","pred":"mondo_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/MONDO_0021201"},{"id":"A64","pred":"mondo_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"192564-14-0 N.D. \u003e100 N.D. N.D.\nDalbavancin hydrochloride antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 2"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T62","span":{"begin":97,"end":101},"obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"id":"T63","span":{"begin":97,"end":101},"obj":"http://purl.obolibrary.org/obo/UBERON_0001003"},{"id":"T64","span":{"begin":97,"end":101},"obj":"http://purl.obolibrary.org/obo/UBERON_0002097"},{"id":"T65","span":{"begin":97,"end":101},"obj":"http://purl.obolibrary.org/obo/UBERON_0002199"},{"id":"T66","span":{"begin":97,"end":101},"obj":"http://www.ebi.ac.uk/efo/EFO_0000962"},{"id":"T67","span":{"begin":136,"end":144},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_2"}],"text":"192564-14-0 N.D. \u003e100 N.D. N.D.\nDalbavancin hydrochloride antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 2"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T151","span":{"begin":44,"end":57},"obj":"Chemical"},{"id":"T152","span":{"begin":58,"end":69},"obj":"Chemical"}],"attributes":[{"id":"A151","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_36807"},{"id":"A152","pred":"chebi_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/CHEBI_33281"}],"text":"192564-14-0 N.D. \u003e100 N.D. N.D.\nDalbavancin hydrochloride antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 2"}

{"project":"LitCovid-sentences","denotations":[{"id":"T64","span":{"begin":27,"end":31},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"192564-14-0 N.D. \u003e100 N.D. N.D.\nDalbavancin hydrochloride antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 2"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":97,"end":111},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0100658"}],"text":"192564-14-0 N.D. \u003e100 N.D. N.D.\nDalbavancin hydrochloride antibiotics FDA approved treatment for skin infection caused by Gram positive bacteria 2"}